Teva loses over FDA over generic production of Copaxone
Israel-based Teva Pharmaceutical Industries Ltd lost another legal challenge to the introduction of generic versions of its lucrative multiple sclerosis drug Copaxone when a judge dismissed its lawsuit against the US Food and Drug Administration over its calls for more additional testing of its rival's drug versions, Bloomberg reported.